CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats

Although bortezomib (BTZ) is the frontline treatment for multiple myeloma, its clinical use is limited by the occurrence of painful peripheral neuropathy, whose treatment is still an unmet clinical need. Previous studies have shown chronic BTZ administration (0.20 mg/kg intravenously three times a w...

Descripción completa

Detalles Bibliográficos
Autores principales: Meregalli, Cristina, Ceresa, Cecilia, Canta, Annalisa, Carozzi, Valentina Alda, Chiorazzi, Alessia, Sala, Barbara, Oggioni, Norberto, Lanza, Marco, Letari, Ornella, Ferrari, Flora, Avezza, Federica, Marmiroli, Paola, Caselli, GianFranco, Cavaletti, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392714/
https://www.ncbi.nlm.nih.gov/pubmed/22792002
http://dx.doi.org/10.2147/JPR.S32122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392714/
https://www.ncbi.nlm.nih.gov/pubmed/22792002
http://dx.doi.org/10.2147/JPR.S32122

Ejemplares similares